Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis
Abstract Several studies have evaluated the efficacy of PD-1/PD-L1 inhibitors in ovarian cancer; however, the response rate varies. This study aims to explore the efficacy of anti-PD-1/PD-L1 therapy in ovarian cancer. A quantitative meta-analysis was performed through a systematic search in PubMed,...
Main Authors: | Jue Zhu, Lifeng Yan, Qiming Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13048-021-00862-5 |
Similar Items
-
Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis
by: Siyuan Zeng, et al.
Published: (2023-03-01) -
The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
by: Lu Wen, et al.
Published: (2021-12-01) -
PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
by: Tianrui Yang, et al.
Published: (2021-02-01) -
Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
by: Surui Liu, et al.
Published: (2022-07-01) -
The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer
by: Nicole E. James, et al.
Published: (2020-08-01)